Phenox

Bochum, Germany Founded: 2005 • Age: 21 yrs Acquired By Wallaby Medical
Developer of medical devices for interventional neurology

About Phenox

Phenox is a Healthcare company based in Bochum (Germany) founded in 2005, and was acquired by Wallaby Medical in April 2022. Developer of medical devices for interventional neurology. Phenox offers products and services including HPC Coating, pRESET, and Flow Diverter. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is phenox GmbH.

Company details

Phenox was founded in 2005 and is based in Bochum, Germany. Medical devices for interventional neurology are developed by the company, focusing on treatments for aneurysms and acute ischemic stroke. Key products include the p64 flow modulation device, pCONus bifurcation aneurysm implant for wide-neck aneurysms, pREset LITE thrombectomy device, and pITA rapid exchange neurovascular PTA balloon catheter. Operations center on innovation in neurovascular interventions.

Operational Areas
Key Metrics

Products & Services of Phenox

Phenox offers a comprehensive portfolio of products and services, including HPC Coating, pRESET, and Flow Diverter.

HPC Coating
Medical Coating

Hydrophilic polymer that reduces thrombosis on implants.

pRESET
Aneurysm Treatment

Device for ischemic stroke management.

Flow Diverter
Aneurysm Treatment

Implant to treat aneurysms with reduced thrombosis risk.

Apps and channels of Phenox

its YouTube channel phenox GmbH has 458 subscribers.

phenox GmbH
YouTube 458 subscribers Science & Technology
Open channel

Funding Insights of Phenox

  • Total Rounds 2
  • Investors Count 2

All 2 funding rounds of Phenox with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2010Series A––
Jul 2008Seed––
Valuation history

3 investors in total: 3 institutional.

Investors in Phenox

Phenox has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include NRW.Bank, Wallaby Medical and SHS Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Healthcare-focused private equity investments are managed by SHS Capital.
1993shs-capital.euTübingen, Germany
Loans, advice, seminars, and networks are provided for financial support.
2001nrwbank.deDusseldorf, Germany
A medical device for stroke treatment is developed.
2016wallabymedical.comLaguna Hills, United States
Premium access

Investor details for Phenox

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Phenox

4 dated milestones of Phenox across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded Phenox is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A,.
  4. Exit Acquired by Wallaby Medical.

Web traffic of Phenox

The website of Phenox (phenox.net) receives about 6.4K visits a month.

  • Monthly visits
    6.4K

    ▲ 156.9% vs previous month

Similar websites

Websites whose visitors overlap most with Phenox. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
medecon.ruhr
medecon.ruhr
100%
#2,824,852–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Phenox

Premium access

Complete news archive for Phenox

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Phenox

Phenox was founded in 2005 and raised its 1st funding round 3 years after it was founded.

Phenox is headquartered in Bochum, Germany. It is registered at Bochum, North Rhine-westphalia, Germany.

Phenox was founded in 2005 and is based in Bochum, Germany. Medical devices for interventional neurology are developed by the company, focusing on treatments for aneurysms and acute ischemic stroke. Key products include the p64 flow modulation device, pCONus bifurcation aneurysm implant for wide-neck aneurysms, pREset LITE thrombectomy device, and pITA rapid exchange neurovascular PTA balloon catheter. Operations center on innovation in neurovascular interventions.

Phenox offers HPC Coating, pRESET, and Flow Diverter.

Phenox has 3 investors. Key investors include NRW.Bank, Wallaby Medical, and SHS Capital.

Phenox operates through Phenox Gmbh.

Yes. Phenox was acquired by Wallaby Medical in April 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available